Based in USA, Polymed Therapeutics has been at the forefront in the manufacture of APIs and Chemicals, with state-of-the-art and regulatory approved cGMP facilities and RD laboratories in China. For the past decade their API division has been a leader in the supply of pharmaceutical grade yet low cost specialty active ingredients and intermediates, for the global market. Their product portfolio has since expanded from Paclitaxel to more oncology APIs, Vitamin D analogues, plus other categories. Their Fine Chemicals division specializes in Custom Synthesis, and serves the global markets of Pharmaceutical and Specialty Chemicals. Their team of scientists is expert in the whole range of manufacture – from RD, pilot scale, to industrial scale. Being flexible and fast, their plants achieve extremely complex or simple synthesis, for large or small demands. Their in-vitro diagnostic devices are rapid testing kits used to detect, prevent, and diagnose various medical conditions. These kits are simple to use and are priced competitively to meet their customers’ needs. Their scientific team of experts manufacture these high quality medical device kits. Polymed is a cGMP facility that meets the ISO standards. Polymed is financially stable, technologically proficient and dedicated to providing the most excellent products and services at competitive costs, to be the optimal strategic supplier to global customers.